Bill > S01801

This bill establishes a pilot program for psilocybin-assisted therapy in New York State, specifically for veterans and first responders, including retired first responders. Psilocybin is a naturally occurring psychedelic compound found in certain fungi, and "medical psilocybin" refers to its use for treating medical conditions or symptoms. The program will provide funding for participants to receive this therapy, with a "facilitator" being a qualified mental health professional or individual with relevant experience. The program will operate in partnership with State University of New York (SUNY) academic health centers and must comply with all federal regulations, including those from the Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA), and will terminate upon federal approval of psilocybin for medical use. The bill also creates a dedicated "psilocybin assisted therapy pilot program fund" to support these operations, with an initial appropriation of $5 million, and ensures that participants and facilitators will not face legal repercussions or professional disciplinary actions solely for their involvement in the program, provided they do not perform their duties while impaired or violate federal law.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S1801